BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20832093)

  • 1. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel.
    Sousa-Figueiredo JC; Day M; Betson M; Kabatereine NB; Stothard JR
    Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):740-2. PubMed ID: 20832093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model.
    Stothard JR
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):325-32. PubMed ID: 19171359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical dosing of praziquantel for schistosomiasis in preschool-aged children.
    Olliaro PL; Vaillant M; Hayes DJ; Montresor A; Chitsulo L
    Trop Med Int Health; 2013 Sep; 18(9):1085-1089. PubMed ID: 23937700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
    Namwanje H; Kabatereine N; Olsen A
    Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):181-8. PubMed ID: 21353271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the WHO dose pole in the Philippines for school-based mass drug administration of praziquantel for morbidity control of schistosomiasis.
    Erfe JM; Belizario VY; Chua PL; Naig JR
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):620-6. PubMed ID: 23986489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma japonicum in hyperendemic areas of the Dongting Lake region, China.
    Yu D; Sarol JN; Hutton G; Tan D; Tanner M
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):441-57. PubMed ID: 12693575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The WHO dose pole for the administration of praziquantel is also accurate in non-African populations.
    Montresor A; Odermatt P; Muth S; Iwata F; Raja'a YA; Assis AM; Zulkifli A; Kabatereine NB; Fenwick A; Al-Awaidy S; Allen H; Engels D; Savioli L
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):78-81. PubMed ID: 15550266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa.
    Baan M; Galappaththi-Arachchige HN; Gagai S; Aurlund CG; Vennervald BJ; Taylor M; van Lieshout L; Kjetland EF
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004623. PubMed ID: 27139497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomiasis in infants and pre-school-aged children in sub-Saharan Africa: implication for control.
    Ekpo UF; Oluwole AS; Abe EM; Etta HE; Olamiju F; Mafiana CF
    Parasitology; 2012 Jun; 139(7):835-41. PubMed ID: 22313588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociocultural aspects of mass delivery of praziquantel in schistosomiasis control: the Abeokuta experience.
    Adeneye AK; Akinwale OP; Idowu ET; Adewale B; Manafa OU; Sulyman MA; Omotola BD; Akande DO; Mafe MA; Appelt B
    Res Social Adm Pharm; 2007 Jun; 3(2):183-98. PubMed ID: 17561219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From a weighing scale to a pole: a comparison of two different dosage strategies in mass treatment of Schistosomiasis haematobium.
    Nordin P; Poggensee G; Mtweve S; Krantz I
    Glob Health Action; 2014; 7():25351. PubMed ID: 25476930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of interventions to control schistosomiasis: A systematic review of the literature.
    Salari P; Fürst T; Knopp S; Utzinger J; Tediosi F
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008098. PubMed ID: 32226008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing of praziquantel by height in sub-Saharan African adults.
    Palha De Sousa CA; Brigham T; Chasekwa B; Mbuya MN; Tielsch JM; Humphrey JH; Prendergast AJ
    Am J Trop Med Hyg; 2014 Apr; 90(4):634-7. PubMed ID: 24591432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Height as a substitute for weight for estimating praziquantel dosage.
    Idowu ET; Mafe MA; Appelt B; Adewale B; Adeneye AK; Akinwale OP; Manafa OU; Akande DO
    World Health Popul; 2007; 9(3):19-26. PubMed ID: 18272939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of a school based mass treatment of schistosomiasis in Ugu District, KwaZulu Natal, South Africa in 2012.
    Maphumulo A; Mahomed O; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
    PLoS One; 2020; 15(6):e0232867. PubMed ID: 32497049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for praziquantel treatment in a hyperendemic community of Ogun State, Nigeria.
    Adeneye AK; Mafe MA; Appelt B; Idowu ET; Akande DO
    Res Social Adm Pharm; 2006 Mar; 2(1):83-95. PubMed ID: 17138502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field test of the 'dose pole' for praziquantel in Zanzibar.
    Montresor A; Engels D; Ramsan M; Foum A; Savioli L
    Trans R Soc Trop Med Hyg; 2002; 96(3):323-4. PubMed ID: 12174788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosomiasis in African infants and preschool children: to treat or not to treat?
    Stothard JR; Gabrielli AF
    Trends Parasitol; 2007 Mar; 23(3):83-6. PubMed ID: 17241815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis.
    Hall A; Nokes C; Wen ST; Adjei S; Kihamia C; Mwanri L; Bobrow E; de Graft-Johnson J; Bundy D
    Trans R Soc Trop Med Hyg; 1999; 93(6):653-8. PubMed ID: 10717759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel: do we need another antischistosoma treatment?
    Fenwick A
    Future Med Chem; 2015; 7(6):677-80. PubMed ID: 25996058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.